Skip to main content

Table 1 Individual subject’s measured menstrual blood loss (mL) per study cycle

From: Potentially effective therapy of heavy menstrual bleeding with an oestradiol-nomegestrol acetate oral contraceptive: a pilot study

 

Pretreatment

COCP start

Treatment cycles

Subject

Cycle 1 (mL)

Cycle 2 (mL)

Cycle 3 (mL)

Cycle 4 (mL)

Cycle 5 (mL)

Cycle 6 (mL)

Cycle 7 (mL)

1

99.5

60.8

128.7

56.6

9.9

24.5

Discontinued

2

73.9

208.4

150.0

35.1

18.9

16.9

25.3

3

42.1

318.3

79.4

28.7

14.7

17.2

28.7

4

87.6

65.0

65.0

92.8

33.8

41.9

25.0

5

127.6

83.6

131.0

194.3

0

27.7

18.1

6

280.9

88.4

58.6

80.4

33.2

42.0

61.5

7

259.1

222.7

244.4

109.0

60.4

13.3

96.8

8

92.8

60

109.5

40.9

6.4

21.6

20.5

9

84.0

130.4

32.9

84.6

6.4

38.3

31.4

10

230.5

104.4

169.6

189.1

0

0

0

11

92.5

212.3

218.8

170.2

Not collected overseas

51.2

61.2

12

137.4

23.0

92.3

47.0

43.5

24.2

29.4

  1. Started E2/NOMAC on the first day of bleeding in this cycle